Oxford BioDynamics signs lease for new lab and office space at Oxford Business Park
Oxford BioDynamics Plc, the biotechnology company developing precision medicine tests for personalized healthcare based on the EpiSwitch 3D genomics platform, has signed a lease agreement for new laboratory and office space at Oxford Business Park, to significantly expand its UK facilities.
The 24,000 sq ft premises will house the Company's growing UK infrastructure, as it continues the execution of its expanded strategic focus, announced in December 2020. The new lease follows the recent launches of OBD's EpiSwitch® CST (Covid Severity Test) and its EpiSwitch® Explorer Array Kit.
The larger space will allow OBD to operate independent processing lines for commercial test development and product support, biomarker discovery contracts, clinical trial support and internal R&D projects. The new facility will also provide custom-designed space for product manufacturing, sample and consumables storage, as well as offices and meeting rooms to accommodate the entire UK team.
Development work is expected to be completed in late July 2021. Financial details were not disclosed.
Dr Jon Burrows, CEO of Oxford BioDynamics, said: "This new lease comes at an exciting time for OBD, following the launch of both our prognostic test for COVID-19 severity and the EpiSwitch® Explorer Array Kit. It marks the next important step of the continued roll-out of our expanded strategic focus.
"We moved into our current reference laboratory on the Oxford Business Park in 2015 and expanded it in 2018; this new lease reflects the next stage of our growth. We enjoy excellent support from our landlord, Arlington, and the team at the Business Park. We are very happy to be staying with them as we grow."
Daniel Williams, Development Director of Arlington, added: "We are delighted to continue supporting the successful growth of Oxford BioDynamics. Signing this new lease at Building 3140 is testament to our customer-focused approach. With our commitment to deliver the highest quality, flexible workspaces within an amenity rich environment, our Life Science community is thriving. We look forward to working with OBD for many more years to come."
